Brief: Rovi Sees 2024 Revenue To Decrease By Mid-Single-Digit Percentage Vs 2023

Laboratorios Farmaceuticos Rovi

31/07/2024 06:38

July 31 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * SEES 2024 REVENUE TO DECREASE BY MID-SINGLE-DIGIT
PERCENTAGE IN
COMPARISON WITH 2023

Source text for Workspace:  ID:nCNM4qBNzl 
Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))